Minimizing Adverse Haemorrhagic Events by TRansradial Access Site and Systemic Implementation of angioX

A phase 3 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 7200 participants.

Also called NCT01433627

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 7,200 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT01433627
  • EudraCT 2011-000430-11
Other papers using this trial's data
  • Access-Site Crossover in Patients With Acute Coronary Syndrome Undergoing Invasive Management JACC. Cardiovascular interventions, 2021-02-22 DOI, PubMed 33602431
  • Acute kidney injury after percutaneous coronary intervention: Rationale of the AKI-MATRIX (acute kidney injury-minimizing adverse hemorrhagic events by TRansradial access site and systemic implementation of angioX) sub-study Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions, 2015-11 DOI, PubMed 25854692 PubMed links an erratum for this paper. Erratum: PMID 27976542
  • Acute kidney injury in patients with acute coronary syndrome undergoing invasive management treated with bivalirudin vs. unfractionated heparin: insights from the MATRIX trial European heart journal. Acute cardiovascular care, 2021-12-18 DOI, PubMed 34491323
  • Bivalirudin or Heparin in Patients Undergoing Invasive Management of Acute Coronary Syndromes Journal of the American College of Cardiology, 2018-03-20 DOI, PubMed 29544607
  • Bivalirudin or Unfractionated Heparin in Acute Coronary Syndromes The New England journal of medicine, 2015-09-10 DOI, PubMed 26324049
  • Choice of access site and type of anticoagulant in acute coronary syndromes with advanced Killip class or out-of-hospital cardiac arrest Revista espanola de cardiologia (English ed.), 2020-11 DOI, PubMed 32151464
  • Impact of Sex on Comparative Outcomes of Radial Versus Femoral Access in Patients With Acute Coronary Syndromes Undergoing Invasive Management: Data From the Randomized MATRIX-Access Trial JACC. Cardiovascular interventions, 2018-01-08 DOI, PubMed 29301646
  • Post-Procedural Bivalirudin Infusion at Full or Low Regimen in Patients With Acute Coronary Syndrome Journal of the American College of Cardiology, 2019-02-26 DOI, PubMed 30784669
  • Prognostic Implications of Declining Hemoglobin Content in Patients Hospitalized With Acute Coronary Syndromes Journal of the American College of Cardiology, 2021-02-02 DOI, PubMed 33509394, PMC8091415 In the PMC Open Access subset under a licence that is not Creative Commons.
  • Prognostic Implications of Evolving Universal Definitions of Periprocedural Myocardial Infarction in Patients With Acute Coronary Syndrome Circulation, 2026-01-27 DOI, PubMed 41493005
  • Radial versus femoral access and bivalirudin versus unfractionated heparin in invasively managed patients with acute coronary syndrome (MATRIX): final 1-year results of a multicentre, randomised controlled trial Lancet (London, England), 2018-09-08 DOI, PubMed 30153988
  • Radial versus femoral access in patients with acute coronary syndromes undergoing invasive management: a randomised multicentre trial Lancet (London, England), 2015-06-20 DOI, PubMed 25791214
  • Ultra-Short Term Evaluation of Coronary Vessel Wall Changes in Reference Segments Adjacent to Culprit Lesions in ST-Segment Elevation Myocardial Infarction The Journal of invasive cardiology, 2021-12 DOI, PubMed 34792483
  • Validation of the Mayo Clinic Percutaneous Coronary Intervention Risk Prediction Score in Patients With Acute Coronary Syndrome Journal of the American Heart Association, 2025-10-21 DOI, PubMed 41065238, PMC12684587 In the PMC Open Access subset under CC BY-NC-ND.

Courtesy of the U.S. National Library of Medicine.

Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Italy (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT01433627. Randomized; single masking; primary purpose treatment. Start 2011-10 (registry gives no type); primary completion 2014-11 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Minimizing Adverse Haemorrhagic Events by TRansradial Access Site and Systemic Implementation of angioX
Acronym
MATRIX
Condition
Acute Coronary Syndromes
Condition
STEMI
Condition
NSTEMI
Intervention (Other)
trans-radial and short-term bivalirudin
Intervention (Other)
trans-radial and long-term bivalirudin infusion
Intervention (Other)
trans-radial and standard of care pharmacology
Intervention (Other)
Trans-femoral and Short-term bivalirudin
Intervention (Other)
trans-femoral and long-term bivalirudin infusion
Intervention (Other)
trans-femoral and standard of care pharmacology
Lead sponsor
Italian Society of Invasive Cardiology (class: other)
Collaborator
Eustrategy (class: other)

Record details

Record id
cardio:ct-nct01433627
Content hash
bd213ae1d3b77a1a1182f0c448ec7b1645187416791af9c62741db75c15bd241